CBT for Medicines-Related Consultations in Cardiac Health.
Research type
Research Study
Full title
Using Cognitive Behavioural Therapy Techniques to Improve Medicines-Related Consultations in the Area of Cardiac Health.
IRAS ID
260615
Contact name
Lindsey H Roberts
Contact email
Sponsor organisation
Oxford University Hospitals NHS Foundation Trust
Duration of Study in the UK
0 years, 6 months, 29 days
Research summary
Cardiovascular disease (CVD) is a chronic condition that affects the blood vessels and heart and can result in death. Across the world, CVD accounts for almost a third of all deaths in the UK. Persistently raised arterial blood pressure is the single biggest risk factor for CVD, is known as hypertension and is associated with at least half of all heart attacks and strokes. Treatment of hypertension can significantly reduce the risk of CVD but treatment effectiveness is limited by medication adherence.
Millions of medicines are wasted each year in the UK, which results in lost benefits to patients, rising NHS treatment costs and contributes to environmental waste. This problem can be directly prevented but needs to be facilitated through putting prevention measures in place, such as supporting patients’ decision-making around their medication regime by healthcare professionals (HCP’s) who are able to offer a person-centred consultation at the point of prescribing.
Our aim is to provide Healthcare Professionals (HCP’s) with training from a newly developed training programme, designed to positively affect patients’ adherence to medication, support positive beliefs about medicines and increase feelings of being in control of their cardiac condition. We also aim to improve HCP work satisfaction, the ability of HCP’s to provide the best quality of care possible and indirectly affect medicines waste and reduce costs. We will achieve these outcomes through a training programme for HCP’s and a questionnaire study for patients to complete before and after their routine consultation. This will be used to establish whether our intervention has had a positive effect, or not on supporting patient decision-making, adherence and reduce medicines waste.
REC name
London - Brent Research Ethics Committee
REC reference
20/LO/0252
Date of REC Opinion
17 Mar 2020
REC opinion
Further Information Favourable Opinion